Neuroone Medical Technologies is trading 7.6% higher in pre-market at $1.06; no new company-specific announcement explaining the October 2 move was identified. - The stock closed at $0.99 on October 1. - Recent company news includes a September 17 distribution agreement, which is not a fresh catalyst. - Major U.S. indexes were higher before the September jobs report, while the supplied healthcare-sector context was negative. Broader sentiment may have contributed, but available evidence does not establish a direct cause.